Association between bone measures and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers.
Kara L Holloway-KewAmelia G BetsonKara B AndersonJames GastonMark A KotowiczWan-Hui LiaoMaciej HennebergJulie A PascoPublished in: Archives of osteoporosis (2021)
Women who used an ACEI medication had lower values for FNBMD, LSBMD and TBS compared to non-users. No differences were identified for men or for those who used ARB medications.
Keyphrases
- angiotensin converting enzyme
- angiotensin ii
- polycystic ovary syndrome
- vascular smooth muscle cells
- bone mineral density
- healthcare
- pregnancy outcomes
- middle aged
- soft tissue
- bone loss
- adverse drug
- cervical cancer screening
- breast cancer risk
- bone regeneration
- metabolic syndrome
- emergency department
- body composition
- insulin resistance
- adipose tissue
- electronic health record